FDA Approved: SYMDEKO — Supplemental Application (Vertex Pharmaceuticals Incorporated)

View source ↗

Summary

The FDA approved Vertex's supplemental application for Symdeko (tezacaftor/ivacaftor), resulting in an updated/expanded label.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Symdeko (tezacaftor/ivacaftor)

Snippet

SUPPL AP for SYMDEKO (TEZACAFTOR AND IVACAFTOR)